[Therapy of patients with chronic coronary artery disease and the actual state of the problem in practical public health].
This review presents the analysis of the results of large controlled studies of the efficiency of lipid-lowering agents, disaggregants, and anti-ischemic drugs for treatment of coronary artery disease (stenocardia). It has been shown that not all preparations in one group are equally efficient. The review also adduces comparative data on the use of the listed groups of pharmaceuticals in different European countries and Russian Federation.